Initial Efforts toward the Optimization of Arylomycins for Antibiotic Activity

Abstract excerpt

While most clinically used antibiotics were derived from natural products, the isolation of new broad-spectrum natural products has become increasingly rare and narrow-spectrum agents are typically deemed unsuitable for development because of intrinsic limitations of their scaffold or target. However, it is possible that the spectrum of a natural product antibiotic might be limited by specific resistance...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biochemical and Structural Characterization
• Share to Microbial Natural Products and Biosynthesis
• Share to Peptidase Inhibition and Analysis